NovaBridge Biosciences Cash Flow Statement (2017-2025) | NBP

1Y3Y5Y7Y10YAll
Download Data
Cash Flow Statement Dec2017 Sep2019 Dec2019 Sep2020 Dec2020 Dec2021 Dec2022 Sep2023 Dec2023 Mar2024 Jun2024 Sep2024 Dec2024 Mar2025 Jun2025 Sep2025 Dec2025
Operating Activities
Net Income (Quarter) -35.10M-49.46M-82.36M160.85M25.04M-30.99M-6.90M34.36M34.36M-3.15M-5.50M-6.83M-72.86M
Depreciation and Depletion (Quarter) 0.43M0.76M0.02M0.02M0.02M0.01M
Cash from Discontinued Operations (Quarter) 34.36M88.32M-88.32M
Gains from Sales and Divestitures (Quarter) 0.09M0.12M0.10M0.08M0.91M
Gains from Investment Securities (Quarter) 0.02M6.68M-0.42M-0.03M-0.76M0.02M0.11M2.00M-0.01M
Non-cash Items (Quarter) 64.84M206.50M0.05M0.22M15.39M
Change in Working Capital (Quarter) -37.12M-19.67M-2.81M-0.20M
Cash from Operations (Quarter) -30.64M-33.64M153.34M22.64M-25.17M7.84M-20.60M
Depreciation, Depletion & Amortization
Amortizatization of Intangibles (Quarter) -0.81M0.18M0.19M0.20M0.20M
Depreciation & Amortization (CF) (Quarter) 0.43M0.76M0.02M0.02M0.02M0.01M
Investing Activities
Capital Expenditures (Quarter) 2.39M1.93M-0.00M-0.04M
Change in Acquisitions & Divestments (Quarter) 48.81M336.02M
Cash from Investing Activities (Quarter) 10.97M-41.43M8.22M104.97M
Financing Activities
Other financing activities (Quarter) -3.22M
Cash from Financing Activities (Quarter) 16.07M280.56M127.47M-3.84M57.73M
Additional items
Exchange Rate Effect (Quarter) -8.86M-3.23M-17.61M0.60M-0.01M0.07M0.19M
Change in Cash (Quarter) -12.45M202.27M271.42M-72.63M-11.06M62.66M-17.43M
Free Cash Flow (Quarter) -33.04M-33.64M151.41M22.64M-25.13M7.84M-20.60M
Net Cash Flow (Quarter) -3.60M205.50M289.03M18.81M-25.17M7.84M142.09M